Contract HHSO100201000026C

Elusys Therapeutics Inc · Department Of Health And Human Services · December 18, 2009

Cost Plus Fixed FeeFull & Open CompetitionNAICS 541711

Elusys Therapeutics Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on December 18, 2009 for $138.26 million of work in research and development in biotechnology. Performance is in Pine Brook, NJ. It was awarded under full and open competition. The contract has been modified 17 times since the base award It uses cost-plus contract pricing. The most recent modification was on August 8, 2024.

Obligated to date
$138.26M
$138,258,202
Current value
$138.26M
Modifications
17
Latest August 8, 2024

Contract details

PIID
HHSO100201000026C
Award type
Definitive Contract
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541711 · Research And Development In Biotechnology
Product / service
Health R&D Services; Health Care Services; Experimental Development
Place of performance
Pine Brook, NJ
First action
December 18, 2009
Latest action
August 8, 2024

Description

ELUSYS 0026C MOD#1 9 DE-OB CANCELLING FUNDS

Modification timeline

  • August 8, 2024
    Mod P00019
    $-499.2K
  • September 27, 2018
    Mod 18
    ELUSYS 0026C MOD#18
    $-3.11M
  • January 31, 2018
    Mod 17
    ELUSYS 0026C MOD#17
    $942.4K
  • February 19, 2016
    Mod 16
    0026C ELUSYS MOD#16
    $0
  • June 26, 2015
    Mod 15
    0026C ELUSYS MOD#13
    $0
  • February 12, 2015
    Mod 14
    0026C ELUSYS MOD#13
    $0
  • December 3, 2014
    Mod 13
    0026C ELUSYS MOD#13
    $0
  • October 1, 2013
    Mod 12
    12/20/2012
    $-1.15M
  • July 19, 2013
    Mod 11
    12/20/2012
    $24.55M
  • December 20, 2012
    Mod 10
    12/20/2012
    $0

Similar contracts

RecipientAgencyDateObligated
University Of IllinoisDepartment Of Health And Human ServicesMarch 26, 2026$2.27M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 25, 2026$9.65M
University Of Texas Medical Branch At GalvestonDepartment Of Health And Human ServicesMarch 23, 2026$1.61M
Regeneron Pharmaceuticals IncDepartment Of Health And Human ServicesMarch 19, 2026$8.60M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.23M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.22M

Top contractors in NAICS 541711

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSO100201000026C?

Contract HHSO100201000026C is a federal contract awarded to Elusys Therapeutics Inc by Department Of Health And Human Services on December 18, 2009 for $138.26 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 17 times since the base award.

Who won contract HHSO100201000026C?

Elusys Therapeutics Inc won contract HHSO100201000026C from Department Of Health And Human Services.

How much is contract HHSO100201000026C worth?

Contract HHSO100201000026C has obligated $138.26 million to date.